sr141716 has been researched along with Gastroesophageal Reflux in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beaumont, H; Boeckxstaens, G; Carlsson, A; Jensen, J; Lehmann, A; Ruth, M | 1 |
| Blackshaw, LA; Brändén, L; Carlsson, A; Jensen, J; Lehmann, A; Nygren, E; Smid, SD | 1 |
| Advenier, C; Chen, HZ; Cui, YY; D'Agostino, B; Finance, O; Marrocco, G; Naline, E; Rinaldi-Carmona, M; Risse, PA; Rossi, F; Zhang, Y | 1 |
1 trial(s) available for sr141716 and Gastroesophageal Reflux
| Article | Year |
|---|---|
Effect of delta9-tetrahydrocannabinol, a cannabinoid receptor agonist, on the triggering of transient lower oesophageal sphincter relaxations in dogs and humans.
Topics: Adult; Animals; Cannabinoid Receptor Agonists; Deglutition; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Esophageal Sphincter, Lower; Female; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Muscle Relaxation; Piperidines; Postprandial Period; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Species Specificity; Young Adult | 2009 |
2 other study(ies) available for sr141716 and Gastroesophageal Reflux
| Article | Year |
|---|---|
Cannabinoid receptor agonism inhibits transient lower esophageal sphincter relaxations and reflux in dogs.
Topics: Analgesics; Animals; Benzoxazines; Dogs; Esophagogastric Junction; Female; Ferrets; GABA-B Receptor Agonists; Gastroesophageal Reflux; Ligands; Male; Mechanoreceptors; Morpholines; Muscle Relaxation; Naphthalenes; Neurons, Afferent; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Vagus Nerve | 2002 |
Cannabinoid CB(2) receptor activation prevents bronchoconstriction and airway oedema in a model of gastro-oesophageal reflux.
Topics: Airway Obstruction; Animals; Benzoxazines; Bronchi; Bronchoconstriction; Camphanes; Cannabinoids; Capillary Permeability; Disease Models, Animal; Dose-Response Relationship, Drug; Esophagus; Extravasation of Diagnostic and Therapeutic Materials; Gastroesophageal Reflux; Guinea Pigs; Hydrochloric Acid; Male; Morpholines; Naphthalenes; Piperidines; Pulmonary Edema; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Respiratory Function Tests; Rimonabant; Trachea | 2007 |